chitosan has been researched along with Choroid Neovascularization in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashmi, U; Khalil, M; Riaz, R; Rukh Abbas, S | 1 |
| Arefian, E; Atyabi, F; Chaharband, F; Daftarian, N; Dinarvand, R; Hajiramezanali, M; Kanavi, MR; Norouzi, P; Varshochian, R | 1 |
| Jacobs, KM; Jiang, P; Ohr, MP; Swindle-Reilly, KE | 1 |
| Abedin Dorkoosh, F; Badiee, P; Dinarvand, R; Khoshayand, MR; Rafiee-Tehrani, M; Varshochian, R | 1 |
| Abe, T; Daigaku, R; Hoshi, A; Kaji, H; Nagai, N; Nakazawa, T; Nezhad, ZK; Nishizawa, M; Saijo, S; Song, Y; Terata, K | 1 |
| Hu, Y; Jin, J; Kompella, UB; Ma, JX; Park, K; Tyagi, P; Xu, X; Zheng, Z; Zhou, KK | 1 |
6 other study(ies) available for chitosan and Choroid Neovascularization
| Article | Year |
|---|---|
Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases.
Topics: Animals; Chitosan; Choroidal Neovascularization; Coated Materials, Biocompatible; Delayed-Action Preparations; Disease Models, Animal; Humans; Liposomes; Rats; Triamcinolone | 2020 |
Trimethyl chitosan-hyaluronic acid nano-polyplexes for intravitreal VEGFR-2 siRNA delivery: Formulation and in vivo efficacy evaluation.
Topics: Chitosan; Choroidal Neovascularization; Drug Compounding; Drug Delivery Systems; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Intravitreal Injections; RNA, Small Interfering; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Chitosan-Polycaprolactone Core-Shell Microparticles for Sustained Delivery of Bevacizumab.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line; Cell Survival; Chitosan; Choroidal Neovascularization; Drug Delivery Systems; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Intravitreal Injections; Macular Degeneration; Microplastics; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyesters; Retina; Swine; Vascular Endothelial Growth Factor A | 2020 |
Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment.
Topics: Bevacizumab; Chitosan; Choroidal Neovascularization; Drug Liberation; Eye, Artificial; Humans; Nanoparticles; Particle Size | 2018 |
Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
Topics: Angiogenesis Inhibitors; Animals; Chitosan; Choroidal Neovascularization; Collagen; Drug Implants; Drug Liberation; Eye; Fluorescein-5-isothiocyanate; Gelatin; Lasers; Male; Methacrylates; Polyethylene Glycols; Ranibizumab; Rats, Sprague-Dawley; Serum Albumin | 2019 |
Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blotting, Western; Capillary Permeability; Chemokine CCL2; Chitosan; Choroidal Neovascularization; Drug Delivery Systems; Enzyme-Linked Immunosorbent Assay; Fluorescein Angiography; Intercellular Adhesion Molecule-1; Intravitreal Injections; Lactic Acid; Male; Nanoparticles; Peptide Fragments; Plasminogen; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Inbred BN; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2011 |